USE OF NEW EUROPEAN FURAZIDINIUM IN THERAPY OF ACUTE INFECTIONS OF THE URINARY TRACTS IN WOMEN

Abstract

Uncomplicated infection of lower urinary tract is one of most common reason to visit a doctor among women. Statistically there are about 36 million cases of acute cystitis registered yearly in Russia. The treatment of acute cystitis is usually empirical, that’s why it is very important to know etiology of the disease. There are some criteria for drug choice for the disease treatment: the sensitivity range of uropathogenic microflora, the effectiveness of a preparation based on clinical trials, tolerance of the patient to the antibacterial drug, low risk of collateral damage, availability of the drug and its price. The author has assessed the treatment effectiveness of Urofuragin (Furazidinum) preparation in case of acute cystitis. This drug is high active against main causative agents of the infection diseases of lower urinary tract. Due to the results of the research cupping of dysuria, hematuria and pain syndrome were recorded in all clinical groups on the 2nd-3rd day of treatment. Normalization of urinalysis had place in 98% of cases (51 patient). Only 4 patients (7,6%) had unwanted side effects during the treatment time: nausea, loss of appetite. All the unwanted side effects were poorly expressed and didn’t require to withdraw the treatment. The results of this research show that Urofuragin (Furazidinum) is an effective antibacterial preparation which is easy to use, has affordable price, wide indications and good tolerance to the drug.